cysteine has been researched along with rifampin in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (36.36) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hedgcoth, C; Juarez, H; Skjold, AC | 1 |
| Abdelal, AT; Ahearn, DG; Ogletree, FF | 1 |
| Black, M | 1 |
| Frimmer, M; Homann, J; Petzinger, E | 1 |
| Aguilera, JA; Anderberg, SJ; Av-Gay, Y; delCardayre, SB; Fahey, RC; Newton, GL; Oh, NN; Unson, MD | 1 |
| Bernkop-Schnürch, A; Biebel, RG; Scholler, S | 1 |
| Buchmeier, NA; Fahey, RC; Koledin, T; Newton, GL | 1 |
| Cheng, J; Gonzalez, FJ; Idle, JR; Krausz, KW; Ma, X | 1 |
| Hernick, M | 1 |
| Hardy, KD; Nelson, SD; Papageorgiou, I; Rettie, AE; Unadkat, JD; Wahlin, MD | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
3 review(s) available for cysteine and rifampin
| Article | Year |
|---|---|
Hepatotoxicity: pathogenesis and therapeutic intervention.
Topics: Acetaminophen; Anabolic Agents; Androgens; Animals; Chemical and Drug Induced Liver Injury; Cysteamine; Cysteine; Erythromycin; Estrogens; Halothane; Humans; Isoniazid; Liver; Nitrofurantoin; Rifampin | 1979 |
Mycothiol: a target for potentiation of rifampin and other antibiotics against Mycobacterium tuberculosis.
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Cysteine; Drug Delivery Systems; Drug Synergism; Enzyme Inhibitors; Glycopeptides; Humans; Inositol; Mycobacterium tuberculosis; Rifampin | 2013 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 other study(ies) available for cysteine and rifampin
| Article | Year |
|---|---|
Precursor relationship of phenylalanine transfer ribonucleic acid from Escherichia coli treated with chloramphenicol or starved for iron, methionine, or cysteine.
Topics: Adenosine; Amino Acids, Sulfur; Amino Acyl-tRNA Synthetases; Arginine; Carbon Radioisotopes; Cell-Free System; Chloramphenicol; Cysteine; Escherichia coli; Iron; Methionine; Phenylalanine; Potassium Permanganate; Rifampin; RNA, Bacterial; RNA, Transfer; Tritium; Tryptophan | 1975 |
Germ-tube formation by atypical strains of Candida albicans.
Topics: Amphotericin B; Animals; Blood; Candida albicans; Cattle; Culture Media; Cysteine; Glucose; Proline; Rifampin; Species Specificity; Spores, Fungal; Temperature; Thioglycolates | 1978 |
[Phalloidin antagonists 4th communication: Thioctic acid, SH-compounds, rifampicin, choleretics, dexamethasone, estradiol, unspecific inhibitors, and ineffective compounds (author's transl)].
Topics: Animals; Chelating Agents; Chemical and Drug Induced Liver Injury; Chloroform; Cholagogues and Choleretics; Coenzyme A; Concanavalin A; Cysteamine; Cysteine; Dexamethasone; Dimercaprol; Estradiol; Female; Male; Oligopeptides; Phalloidine; Rats; Rifampin; Sulfhydryl Compounds; Thioctic Acid | 1975 |
Characterization of Mycobacterium smegmatis mutants defective in 1-d-myo-inosityl-2-amino-2-deoxy-alpha-d-glucopyranoside and mycothiol biosynthesis.
Topics: Culture Media; Cysteine; Disaccharides; Drug Resistance, Microbial; Genetic Complementation Test; Glucosides; Glycopeptides; Hydrogen Peroxide; Inositol; Isoniazid; Mutagenesis; Mycobacterium smegmatis; Pyrazoles; Rifampin; Sulfhydryl Compounds | 1999 |
Development of controlled drug release systems based on thiolated polymers.
Topics: Acrylic Resins; Adhesives; Adsorption; Carboxymethylcellulose Sodium; Cysteine; Delayed-Action Preparations; Disulfides; Drug Carriers; Freeze Drying; Hydrogen-Ion Concentration; Mucous Membrane; Pharmaceutic Aids; Polymers; Rifampin; Solubility; Sulfhydryl Compounds; Tablets, Enteric-Coated; Water | 2000 |
Association of mycothiol with protection of Mycobacterium tuberculosis from toxic oxidants and antibiotics.
Topics: Amidohydrolases; Anti-Bacterial Agents; Antitubercular Agents; Bacterial Proteins; Benzene Derivatives; Catalase; Cell Division; Culture Media; Cysteine; Disaccharides; Drug Resistance, Multiple, Bacterial; Glycopeptides; Inositol; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium smegmatis; Mycobacterium tuberculosis; Oleic Acid; Oxidants; Pyrazoles; Rifampin; Sulfhydryl Compounds | 2003 |
Rifampicin-activated human pregnane X receptor and CYP3A4 induction enhance acetaminophen-induced toxicity.
Topics: Acetaminophen; Alanine Transaminase; Analgesics, Non-Narcotic; Animals; Anti-Bacterial Agents; Aspartate Aminotransferases; Biomarkers; Biotransformation; Chemical and Drug Induced Liver Injury; Cysteine; Cytochrome P-450 CYP3A; Drug Interactions; Enzyme Induction; Glutathione; Humans; Hydrogen Peroxide; Liver; Liver Diseases; Lysophosphatidylcholines; Male; Metabolomics; Mice; Mice, Knockout; Mice, Transgenic; Necrosis; Oxidative Stress; Pregnane X Receptor; Principal Component Analysis; Receptors, Steroid; Rifampin; RNA, Messenger; Time Factors | 2009 |
Studies on the role of metabolic activation in tyrosine kinase inhibitor-dependent hepatotoxicity: induction of CYP3A4 enhances the cytotoxicity of lapatinib in HepaRG cells.
Topics: Biotransformation; Cell Line, Tumor; Cell Survival; Cysteine; Cytochrome P-450 CYP3A; Dexamethasone; Glutathione; Hepatocytes; Humans; Lapatinib; Liver; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Quinazolines; Rifampin | 2014 |